Literature DB >> 1202111

Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells.

P B Jahrling, L Gorelkin.   

Abstract

A benign small-plaque clone of Venezuelan equine encephalitis virus was efficiently removed from the blood of inoculated hamsters by adsorption to cells of the hepatic reticuloendothelial system. More than 99% of infectious small-plaque virus, intrinsically labeled with 32P, was cleared from the blood within 30 min of inoculation; 47.6% of the 32P-labeled small-plaque virus inoculum was concentrated in the liver. In contrast, only 0.8% of a virulent large-plaque clone of the virus was cleared from the blood. The affinity of small-plaque virus for liver tissue was confirmed by electron microscopy, since inoculated small-plaque virions were readily visualized in phagocytic vacuoles of hepatic endothelial and Kupffer cells, where they appeared to be undergoing degradation. In contrast, large-plaque virus was not visualized in the liver. A critical determinant of virulence for viruses that do not replicate in hepatic reticuloendothelial cells may be the efficiency with which they are removed from the blood by adsorption to such cells.

Entities:  

Mesh:

Year:  1975        PMID: 1202111     DOI: 10.1093/infdis/132.6.667

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.

Authors:  W E Brandt; J M McCown; F H Top; W H Bancroft; P K Russell
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

3.  Evaluation of vascular clearance as a marker for virulence of alphaviruses: disassociation of rapid clearance with low virulence of venezuelan encephalitis virus strains in guinea pigs.

Authors:  P B Jahrling; G B Heisey; R A Hesse
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

4.  Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection.

Authors:  Christopher B Brooke; Alexandra Schäfer; Glenn K Matsushima; Laura J White; Robert E Johnston
Journal:  J Gen Virol       Date:  2011-12-28       Impact factor: 3.891

5.  Binding of Sindbis virus to cell surface heparan sulfate.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Chromatographic separations of alphavirus strains by hydroxylapatite.

Authors:  P B Jahrling; J L Beall
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

7.  Correlation between virus-cell receptor properties of alphaviruses in vitro and virulence in vivo.

Authors:  S C Marker; P B Jahrling
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

8.  Enzyme-linked immunosorbent assay detection of immunoglobulins G and M to Venezuelan equine encephalomyelitis virus in vaccinated and naturally infected humans.

Authors:  R R Rosato; F F Macasaet; P B Jahrling
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

9.  A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads.

Authors:  Tyler R Prestwood; Daniil M Prigozhin; Kristin L Sharar; Raphaël M Zellweger; Sujan Shresta
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.

Authors:  P B Jahrling; E H Stephenson
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.